Moore Dannielle K, Loxton Andre G
DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Cape Town, South Africa, 8000.
South African Medical Research Council Centre for Tuberculosis Research, Stellenbosch University, Cape Town, South Africa, 8000.
Immunotherapy. 2019 Jun;11(8):691-704. doi: 10.2217/imt-2018-0185. Epub 2019 Apr 10.
The role of B lymphocytes (B cells) in immunogenic responses has become increasingly important over the past decade, focusing on a new B-cell subtype: regulatory B-cells (B). These B have been shown to possess potent immunosuppressive activities and have identified as key players in disease control and immune tolerance. In this review, the occurrence of B type in various conditions, along with evidence supporting discovered functions and proposed purposes will be explored. An example of such regulatory functions includes the induction or suppression of various T lymphocyte phenotypes in response to a particular stimulus. Should B prove effective in mediating immune responses, and correlate with favorable disease outcome, they may serve as a novel therapeutic to combat disease and prevent infection. However, the induction, function and stability of these cells remain unclear and further investigation is needed to better understand their role and therapeutic efficacy.
在过去十年中,B淋巴细胞(B细胞)在免疫原性反应中的作用变得越来越重要,这聚焦于一种新的B细胞亚型:调节性B细胞(Breg)。这些Breg已被证明具有强大的免疫抑制活性,并被确定为疾病控制和免疫耐受的关键参与者。在这篇综述中,将探讨Breg在各种情况下的出现,以及支持其已发现功能和提出目的的证据。这种调节功能的一个例子包括在特定刺激下诱导或抑制各种T淋巴细胞表型。如果Breg被证明能有效介导免疫反应,并与良好的疾病结果相关,它们可能成为对抗疾病和预防感染的一种新型治疗方法。然而,这些细胞的诱导、功能和稳定性仍不清楚,需要进一步研究以更好地了解它们的作用和治疗效果。